ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,365Medicare Part D Prescriptions Filled, Including Refills

Rank: 417 out of 1107

$547K Total Retail Price of All Prescriptions

Rank: 333 out of 1107

462 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 4,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 340 149 S3 1 1
LISINOPRIL 287 181 2 2
OMEPRAZOLE 250 171 3 4
SIMVASTATIN 250 159 3 5
LEVOTHYROXINE SODIUM 238 182 5 3
GABAPENTIN 232 122 6 9
PRAVASTATIN SODIUM 188 109 7 12
METFORMIN HCL 184 120 8 8
AMLODIPINE BESYLATE 157 135 9 6
CITALOPRAM HBR 139 108 10 17
FUROSEMIDE 138 109 11 7
NEXIUM 133 68 12 18
METOPROLOL SUCCINATE 132 96 13 16
PROMETHAZINE HCL 128 28 R 14 44
ZOLPIDEM TARTRATE 127 54 15 22
POTASSIUM CHLORIDE 112 90 16 14
MELOXICAM 97 46 17 25
PROAIR HFA 96 44 18 37
METOPROLOL TARTRATE 95 67 19 10
CRESTOR 94 42 20 23
ATENOLOL 94 75 20 19
ATORVASTATIN CALCIUM 89 56 22 13
PANTOPRAZOLE SODIUM 85 53 23 30
PLAVIX 82 47 24 39
CARISOPRODOL 79 19 R 25 146
WARFARIN SODIUM 78 65 26 15
DONEPEZIL HCL 75 73 27 32
GLIMEPIRIDE 70 51 28 43
FLUOXETINE HCL 65 26 29 47
HYDROCHLOROTHIAZIDE 64 23 30 11
AZITHROMYCIN 63 25 31 35
CYCLOBENZAPRINE HCL 61 14 R 32 56
TIZANIDINE HCL 59 28 33 73
CLOPIDOGREL 58 20 34 28
RANITIDINE HCL 58 43 34 21
ROPINIROLE HCL 57 0 36 69
LOSARTAN POTASSIUM 56 50 37 29
IBUPROFEN 53 24 38 63
ESCITALOPRAM OXALATE 51 18 39 82
HYDROXYZINE PAMOATE 50 0 R 40 152
ESTRADIOL 50 0 R 40 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.